Read news on myeloid with our app.
Read more in the app
Carrier-free peptide–daunorubicin–small interfering RNA nanoassembly for targeted therapy of acute myeloid leukemia - EurekAlert!
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia - EurekAlert!
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients - EurekAlert!
Sylvester researchers lead major treatment overhauls for acute myeloid leukemia - EurekAlert!
Abnormal transport signal on mutant UBTF gene drives high-risk acute myeloid leukemia - EurekAlert!
Immunotherapy resistance in kidney cancer driven by myeloid cell signaling - EurekAlert!
Myeloid immune cells may offer a new target for immunotherapy in liver cancer - EurekAlert!
Novel drug combination is safe and benefits people with acute myeloid leukemia who have a specific genetic profile - EurekAlert!
Driving the CAR to fight acute myeloid leukemia
Digital PCR can reliably determine if chronic myeloid leukemia patients in remission can successfully discontinue drug treatment
A prognostic model for acute myeloid leukemia based on ferroptosis-related lncRNA and immune infiltration analysis - EurekAlert
Study unveils key immune cells found to boost cancer treatment success in acute myeloid leukemia - EurekAlert
Study unveils key immune cells found to boost cancer treatment success in acute myeloid leukemia
Researchers awarded $1.3M to help military Veterans battling Acute Myeloid Leukemia - EurekAlert
Study identifies genetic factors crucial in acute myeloid leukemia survival for Black patients
Triplet regimen yields promising response in advanced-phase chronic myeloid leukemia
P-bodies sustain acute myeloid leukemia
Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia - EurekAlert
A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan (2024)
How a protein component of nuclear pore complexes regulates development of blood cells and may contribute to myeloid disorders
